Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Texas Instruments (TXN) Seems To Expect The Downturn To Be Protracted, PT Down To $100 At Nomura
-
Juniper Networks (JNPR) Cloud Recovery Remains Elusive - Nomura
-
4 Key Takeaways From Total System Services (TSS) Report - Nomura
-
New Oriental Education (EDU) PT Lowered to $100 at Nomura/Instinet
-
S&P Global (SPGI) PT Lowered to $198 at Nomura/Instinet
-
Moody's Corp (MCO) PT Lowered to $190 at Nomura/Instinet
-
Nomura/Instinet Upgrades Fifth Third Bancorp (FITB) to Neutral
-
Nomura Sees Apple (AAPL) iPhone 8XR Shipment Times Consistent With Prior Cycles
-
Nomura Raises Worldpay (WP) PT To $125 Ahead of Earnings
-
Nomura/Instinet Downgrades Indian Oil Corp Ltd. (IOCL:IN) to Neutral
-
Nomura/Instinet Downgrades Hindustan Petroleum Corp Ltd. (HPCL:IN) to Neutral
-
Nomura/Instinet Downgrades Bharat Petroleum Corp. (BPCL:IN) (BRQPY) to Neutral
-
NTT Communications Rated First for Growth in Customer Loyalty
-
Mitsubishi Heavy's struggling aircraft unit to gain $2 billion lifeline: NHK
-
ALTSO’s Hedge Fund Rocktoberfest NYC Announces Main Stage and Acoustic Room Lineup and Unique Features at Thursday’s 15th Anniversary Charity Event
-
Creekstone Farms Premium Beef LLC Announces New $35 Million Distribution Center
-
Nomura/Instinet Downgrades Hyundai Steel Co (004020:KS) to Neutral
-
Exelixis (EXEL) Highlights Results from Dose-Escalation Stage of Phase 1b COSMIC-021 Study of Cabozantinib in Combination with Atezolizumab
-
Exelixis Announces Results from the Dose-Escalation Stage of the Phase 1b COSMIC-021 Study of Cabozantinib in Combination with Atezolizumab in Previously Untreated Advanced Renal Cell Carcinoma
-
Exelixis (EXEL) Highlights Results from Two Analyses Evaluating Effect of PD-L1 Expression or Prior Treatment with Checkpoint Inhibitors on Efficacy of Cabozantinib
-
Nomura/Instinet Upgrades Intel (INTC) to Buy
-
SBI Life Insurance Co Ltd (SBILIFE:IN) PT Lowered to INR725 at Nomura/Instinet
-
Radiant Opto-Electronics Corp (6176:TT) PT Raised to NT$77.30 at Nomura/Instinet
-
Luxshare Precision (002475:CH) PT Lowered to RMB19.40 at Nomura/Instinet
-
Nomura/Instinet Upgrades Astro Malaysia Holdings Bhd (ASTRO:MK) to Neutral
-
China's tax cuts next year expected to reach 1 percent of GDP: PBOC adviser
-
Exelixis Announces Results from Two Analyses Evaluating Effect of PD-L1 Expression or Prior Treatment with Checkpoint Inhibitors on Efficacy of Cabozantinib in Patients with Advanced Renal Cell Carcin
-
SolarWinds (SWI) IPO Opens Modestly Higher
-
Nomura/Instinet Reiterates Buy on Incyte (INCY) Ahead of 3Q earnings Release
-
KeyCorp (KEY) PT Lowered to $22 at Nomura/Instinet
-
American Express (AXP) PT Raised to $130 at Nomura/Instinet
-
Frost & Sullivan Briefing Explores the Impact of Brexit on the UK Economy and Industry
-
PayPal (PYPL) Concerns Were Overblown, Short Squeeze Likely - Nomura
-
Nomura/Instinet Downgrades Samsonite International SA (1910:HK) (SMSOF) to Neutral
-
SolarWinds Announces Pricing of Initial Public Offering
-
SolarWinds Announces Pricing of Initial Public Offering
-
Global Blood Therapeutics (GBT): FDA-ASH SCD Workshop AM Portends Approval - Nomura/Instinet
-
Tone And Outlook Set U.S. Bancorp (USB) Apart - Nomura
-
Royal Caribbean Cruises (RCL) PT Tweaked Down To $153 Ahead Of Earnings At Nomura
-
M&T Bank (MTB) PT Lowered to $178 at Nomura/Instinet
-
Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Lowered to RMB50 at Nomura/Instinet
-
Hero MotoCorp Ltd. (HMCL:IN) PT Lowered to INR3,542 at Nomura/Instinet
-
Nomura/Instinet Upgrades IRPC PCL (IRPC:TB) (IRPTF) to Buy
-
Orchid Island Capital Announces October 2018 Monthly Dividend and September 30, 2018 RMBS Portfolio Characteristics
-
TRANSACT Tech San Francisco to Examine the Impact of Software Providers on the Payments Industry
-
ServiceNow Invests for Growth in Japan
-
TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing
-
SoftBank lines up $9 billion in loans for Vision Fund from banks: Bloomberg
-
Nomura Expects Modest But Achievable Targets At Hewlett Packard Enterprise's (HPE) Investor Day
-
Netflix (NFLX) Increases Focus On Original Content - Nomura

